LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank17
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-67.90M
↓ 68% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-40.48M
Historical baseline
PeriodValueYoY Change
TTM$-67.90M-15.9%
2024$-58.61M+19.1%
2023$-72.43M-590.9%
2022$-10.48M+82.7%
2021$-60.44M-347.7%
2020$-13.50M-46451.7%
2019$-29000.00-